RareDiseasesNews.net

Rare diseases Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Idiopathic pulmonary fibrosis"

Idiopathic pulmonary fibrosis ( IPF ) is a devastating disease that probably involves several genetic loci. Several rare genetic variants and one common single nucleotide polymorphism ( SNP ) of MUC5B ...


The application for marketing authorisation of Nintedanib, a tyrosine kinase inhibitor ( TKI ), for the treatment of idiopathic pulmonary fibrosis ( IPF ) has been validated and granted accelerated as ...


In two of three phase 3 trials, Pirfenidone ( Esbriet ), an oral antifibrotic therapy, reduced disease progression, as measured by the decline in forced vital capacity ( FVC ) or vital capacity, in pa ...


The FDA ( Food and Drug Administration ) has approved Esbriet ( Pirfenidone ) as a treatment for idiopathic pulmonary fibrosis ( IPF ) in the United States. Idiopathic pulmonary fibrosis is a fatal ...